RESPONSE TO RITUXIMAB TREATMENT IN MALE AND FEMALE PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS

被引:0
|
作者
Ananyeva, Lidia
Garzanova, Liudmila
Koneva, Olga
Desinova, Oxana
Starovoytova, Mayya
Ovsyannikova, Olga
Shayakhmetova, Rushana
Khelkovskaya-Sergeeva, Anna
Babak, Valeriya
机构
关键词
D O I
暂无
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
引用
收藏
页码:6405A / 6405A
页数:1
相关论文
共 50 条
  • [31] RITUXIMAB IN SYSTEMIC SCLEROSIS-INTERSTITIAL LUNG DISEASE, A CASE SERIES OF 18 PATIENTS
    Guzelant, G.
    Melikoglu, M.
    Musellim, B.
    Yilmaz, D. D.
    Fresko, I.
    Seyahi, E.
    Hatemi, G.
    Ugurlu, S.
    Harnuryudan, V.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1274 - 1274
  • [32] Recent advances in the treatment of systemic sclerosis associated interstitial lung disease
    Kamenova, Antoniya
    Tzouvelekis, Argyris
    Margaritopoulos, George A.
    FRONTIERS IN MEDICINE, 2023, 10
  • [33] Nintedanib for the treatment of systemic sclerosis-associated interstitial lung disease
    Yamasaki, Yoshioki
    Kuwana, Masataka
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (06) : 547 - 560
  • [34] Efficacy of Cyclophospamide in the Treatment of Interstitial Lung Disease Associated with Systemic Sclerosis
    Espinosa, Gerard
    Pilar Simeon, Carmen
    Plasin, Miguel Angel
    Xaubet, Antoni
    Munoz, Xavier
    Fonollosa, Vicent
    Cervera, Ricard
    Vilardell, Miguel
    ARCHIVOS DE BRONCONEUMOLOGIA, 2011, 47 (05): : 239 - 245
  • [35] Rituximab in Systemic Sclerosis-Interstitial Lung Disease, a Case Series of 18 Patients
    Guzelant, Gul
    Melikoglu, Melike
    Musellim, Benan
    Yilmaz, Deniz Demir
    Fresko, Izzet
    Seyahi, Emire
    Hatemi, Gulen
    Ugurlu, Serdal
    Hamuryudan, Vedat
    ARTHRITIS & RHEUMATOLOGY, 2016, 68
  • [36] Rituximab in Patients with Systemic Sclerosis-associated Interstitial Lung Disease A Systematic Review and Meta-Analysis
    Macrea, Madalina
    Ghazipura, Marya
    Herman, Derrick
    Barnes, Hayley
    Knight, Shandra L.
    Silver, Richard M.
    Montesi, Sydney B.
    Raghu, Ganesh
    Hossain, Tanzib
    ANNALS OF THE AMERICAN THORACIC SOCIETY, 2024, 21 (02) : 317 - 327
  • [37] Factors associated with the development of interstitial lung disease in patients with systemic sclerosis
    Rebolledo, Maria Milena Pertuz
    Arias, Tamara G.
    Meiller, MARiA JOSe LoPEZ
    Dubinsky, Diana
    MEDICINA-BUENOS AIRES, 2022, 82 (05) : 740 - 745
  • [38] PREGNANCY OUTCOMES IN PATIENTS WITH INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS
    Goloeva, Regina
    Ananyeva, Lidia
    Koneva, Olga A.
    Garzanova, Liudmila
    CHEST, 2023, 164 (04) : 5477A - 5477A
  • [39] CORRELATION BETWEEN INTERSTITIAL LUNG DISEASE ASSOCIATED WITH SYSTEMIC SCLEROSIS AND C-REACTIVE PROTEIN AND RESPONSE ON RITUXIMAB THERAPY
    Garzanova, Liudmila
    Ananyeva, Lidia
    Koneva, Olga A.
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    Shayakhmetova, Rushana
    Khelkovskaya-Sergeeva, Anna
    CHEST, 2023, 164 (04) : 3107A - 3108A
  • [40] Azathioprine Compared to Mycophenolate Mofetil Treatment in Patients with Interstitial Lung Disease Associated with Systemic Sclerosis
    Shell, J.
    Kapralik, J.
    Jones, A.
    Farooqi, M.
    Beattie, K.
    Kolb, M. R.
    Cox, G. P.
    Scallan, C. J.
    Larche, M. J.
    Khalidi, N. A.
    Hambly, N.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)